CNS LESION
Clinical trials for CNS LESION explained in plain language.
Never miss a new study
Get alerted when new CNS LESION trials appear
Sign up with your email to follow new studies for CNS LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New brain scan dye tested as safer alternative
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which uses manganese instead of gadolinium, to see if it could safely and effectively detect lesions in the brain and central nervous system. It involved 18 adults with known conditions like brain tumors or multiple scler…
Matched conditions: CNS LESION
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
Sharper brain scans? new MRI dye aims for clearer tumor pictures
Diagnosis CompletedThis trial tested a new dye (gadopiclenol) injected during MRI scans to see if it helps doctors get clearer pictures of brain lesions, like tumors. It involved 260 patients worldwide who each received two MRI scans: one with the new dye and one with a standard dye. The main goal …
Matched conditions: CNS LESION
Phase: PHASE3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated Mar 27, 2026 12:41 UTC